1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Starling Oncology director Brad Hively told the company on September 1, 2026 that he will not stand for re-election to the Board at the 2027 annual meeting. He remains a director until that meeting but immediately stepped down as Vice Chairman and from the Compliance Committee and other Board committees. The company says the decision did not stem from any disagreement over its operations, policies or practices.
Brad Hively will not stand for re-election to the Board at the 2027 annual meeting of stockholders.
Hively remains a director until the 2027 annual meeting, per the filing.
Effective immediately, Hively no longer serves as Vice Chairman or on the Compliance Committee or other Board committees.
The filing states the decision was not the result of any disagreement with the company.
Barfresh's chief financial officer, Lisa Roger, is retiring with a last day of September 1, 2026, and chief executive Riccardo Delle Coste will serve as interim CFO. The company also named Philip Meneses as Controller (principal accounting officer) effective August 28, 2026, and director Alexander H. Ware, who chaired the Audit Committee, will resign effective September 15, 2026.
CFO Lisa Roger's last day is September 1, 2026; CEO Riccardo Delle Coste will serve as interim CFO.
Philip Meneses appointed Controller effective August 28, 2026, with an annual base salary of $130,000, bonus eligibility of up to 15% of that amount, and 20,800 restricted stock units subject to vesting.
Director Alexander H. Ware gave notice on August 31, 2026 of his resignation effective September 15, 2026; he chaired the Audit Committee. The filing says the resignation was not due to a disagreement with the company.
Chan Heng Fai resigned as Chairman and Chief Executive Officer of HWH International Inc. effective September 1, 2026, and will remain a director. Liu Ming Hui becomes Chairman and Liu Ming Xing becomes CEO; both are brothers tied to majority stockholder Smart Dynamics Technology Limited, which bought shares and warrants from the company on August 10, 2026. The filing names HWH International Inc. (Nasdaq: HWH), not EnerSyn Global Inc., so the company identity in the request should be checked.
Chan Heng Fai, 81, resigned as Chairman and CEO on September 1, 2026, and continues as a board member.
Liu Ming Hui was appointed Chairman (press release says Executive Chairman); Liu Ming Xing was appointed CEO.
Liu Ming Hui and Liu Ming Xing are brothers; Liu Ming Hui owns Smart Dynamics, the majority stockholder.
On August 10, 2026, Smart Dynamics bought 20,000,000 common shares and warrants for up to 160,000,000 shares for $10,000,000 under a securities purchase agreement amended June 8, 2026.
The LGL Group completed its redomestication from Delaware to Nevada on September 1, 2026, after stockholders approved the change at the May 12, 2026 annual meeting. Each share converted one-for-one, and stockholders need not exchange certificates; the stock continues to trade on NYSE American as LGL. The filing says business, management, assets, and liabilities are unchanged, but stockholder rights now fall under Nevada law and the new Nevada articles and bylaws.
Effective 4:00 p.m. Eastern Time on September 1, 2026; the company is now governed by the Nevada Revised Statutes
Each outstanding common share converted one-for-one into a share of the Nevada corporation; no action required from holders
Stockholder rights comparison is in the April 2, 2026 definitive proxy statement; the new articles and bylaws are filed as Exhibits 3.1 and 3.2
Amrize Ltd's Board appointed Zane Nielsen as Chief Accounting Officer and Corporate Controller, effective September 1, 2026, replacing Richard Hoffman as principal accounting officer. Nielsen has been the company's Head of External Reporting since its June 2025 spin-off from Holcim Ltd. The change is administrative in nature and the filing discloses no financial results.
Zane Nielsen appointed Chief Accounting Officer and Corporate Controller, effective September 1, 2026
Nielsen replaces Richard Hoffman as principal accounting officer
Offer Letter sets a $350,000 base salary, 50% annual bonus target and 60% long-term incentive target beginning in 2027
Quantum Corporation named Hiral A. Patel as Chief Accounting Officer and Principal Accounting Officer, effective September 1, 2026, replacing no predecessor named in the filing. The filing sets her base salary at $335,000, a target bonus of 50% of salary, and a grant of 50,000 restricted stock units, along with change of control and standard severance terms. The appointment is a routine finance leadership change with no reported financial results.
Hiral A. Patel appointed Chief Accounting Officer and Principal Accounting Officer, effective September 1, 2026
Offer letter: base salary of $335,000 and target bonus of 50% of base salary
Inducement grant of 50,000 RSUs vesting in three equal annual installments, expected effective on or around October 1, 2026
Change of control agreement provides 12 months of base salary plus 100% of target bonus if terminated within 3 months before to 12 months after a change of control
Hornbeck Offshore completed mergers with Legacy Hornbeck, as shown by new Jones Act warrant agreements dated September 1, 2026, and a reconstituted board with William L. Transier as chairman. The filing also shows the termination of a $120 million Helix credit facility with no outstanding borrowings, an increase in revolving commitments to $125 million, and the departure of the chief executive, chief financial officer and general counsel.
Company issued 37,818,435 shares of common stock to consenting Legacy Hornbeck stockholders and assumed 8,617,903 Jones Act Warrants.
Helix terminated its $120 million asset-based credit facility with Bank of America; there were no outstanding borrowings.
First Incremental Facility Amendment raises revolving commitments to $125 million from $75 million, with $175 million of uncommitted incremental capacity.
Owen Kratz (CEO), Erik Staffeldt (CFO) and Ken Neikirk (general counsel) no longer hold their roles as of the Effective Time; Transier was appointed chairman.
Intellinetics CEO Matthew Chretien notified the company on August 26, 2026, that he will retire and resign as Secretary and Chief Strategy Officer, effective September 1, 2026. The company expects to enter a separation agreement with him, but the material terms have not been determined and will be disclosed later if required.
Matthew Chretien notified the company on August 26, 2026, of his retirement.
His resignations as Secretary and Chief Strategy Officer take effect September 1, 2026.
A separation agreement is expected, but its material terms have not been determined.
The 8-K is signed by Alison Forsythe, President and Chief Executive Officer, and dated September 1, 2026.
Yum! Brands completed the sale of its global Pizza Hut business, excluding mainland China, to Toppings TopCo, LLC (identified in the press release as LongRange Capital) on September 1, 2026, for $1,488,000,000 in cash, subject to adjustments. Pizza Hut China was sold separately to Yum China Holdings, Inc., which closed on August 7, 2026, bringing the two transactions to $2.7 billion in aggregate. Pizza Hut CEO Aaron Powell resigned from all Company positions effective the same day.
Pizza Hut ex-China sold for approximately $1.5 billion in cash, plus a possible earn-out of $75 million by 2030 tied to future performance
Pizza Hut China sale to Yum China Holdings, Inc. closed August 7, 2026; combined sale value $2.7 billion
Aaron Powell resigned as Pizza Hut CEO and from all other Company positions effective September 1, 2026
Chris Turner, Chief Executive Officer of Yum! Brands, describes the company as now more focused
Korn Ferry completed its acquisition of AMS, a UK-headquartered talent and organizational consulting firm, on September 1, 2026. The company paid about £473 million and $326 million in cash and issued 3,118,628 shares of common stock to the sellers, and the combined firm now has nearly 17,000 colleagues in more than 130 offices. Shareholders will see the share issuance and cash outlay, and the financial statements and pro forma information for the deal have not yet been filed.
Acquisition closed September 1, 2026; AMS is now an indirect wholly owned subsidiary of Korn Ferry
Cash paid: about £473 million and $326 million, covering seller proceeds, AMS debt repayment and other obligations
Issued 3,118,628 shares of Korn Ferry common stock to the sellers, exempt from registration under Section 4(a)(2)
Financial statements and pro forma information will be filed by amendment within 71 calendar days
Moderna completed a private offering of $3.0 billion in 0.00% convertible senior notes due March 1, 2032, including the full exercise of a $400 million option for additional notes. The notes carry no regular interest, and the company expects about $285.0 million of net proceeds to go toward the cost of capped call transactions, with the rest for general corporate purposes, which may include oncology growth and debt repayment.
Offering size: $3.0 billion aggregate principal, including $400 million from the initial purchasers' option, completed September 1, 2026
Initial conversion price of about $210.58 per share, a 47.5% premium over the $142.77 closing price on August 27, 2026
Capped call transactions cost approximately $285.0 million; estimated net proceeds are about $2,957.3 million including the option
Notes may not be redeemed before September 6, 2029, except in a cleanup redemption
On August 31, 2026, Spire Inc. entered into a $400 million delayed draw senior unsecured term loan agreement with a group of banks led by Mizuho Bank and U.S. Bank. The company may request up to four borrowings for general corporate purposes until the earliest of full utilization, the fourth borrowing, or December 31, 2026, which gives it committed borrowing capacity but does not by itself state any amount drawn.
Facility size: $400 million of senior unsecured term loan commitments
Borrowing window ends on the earliest of full utilization, the fourth borrowing, or December 31, 2026
Interest at a base rate or Adjusted Term SOFR plus 0.80% per annum; loans mature 364 days after the effective date
Requires a consolidated capitalization ratio of no more than 70% at each fiscal quarter end
Polaryx Therapeutics appointed Will Charlton, M.D., M.A.S., as its Chief Medical Officer, effective September 1, 2026, ahead of the planned SOTERIA Phase 2 trial start in the fourth quarter of 2026. The filing describes his prior roles as Chief Medical Officer at Spruce Biosciences and senior clinical development executive at Tyra Biosciences, and the company says his experience supports its clinical leadership. The filing contains no financial results or guidance, so the appointment is a leadership change rather than a change in reported performance.
Will Charlton, M.D., M.A.S., appointed Chief Medical Officer effective September 1, 2026; appointment announced August 27, 2026 and disclosed in a press release dated September 1, 2026
Previously Senior Vice President, Clinical Development, Skeletal Dysplasia at Tyra Biosciences (March 2025 to June 2026) and Chief Medical Officer at Spruce Biosciences (March 2022 to January 2025)
Company plans to initiate the SOTERIA Phase 2 trial of lead candidate PLX-200 in the fourth quarter of 2026; the company received an FDA safe to proceed letter in October 2025
On September 1, 2026, Perella Weinberg Partners filed a prospectus supplement under its effective S-3ASR shelf registration covering resale of 1,127,529 Class A common shares by certain stockholders. The company is not selling these shares, so the filing itself does not change its share count from the company's issuance, though resales could add supply in the market.
Shares offered for resale: 1,127,529 Class A common stock, par value $0.0001 per share
Filed September 1, 2026 under Form S-3ASR, File No. 333-289189
Mayer Brown LLP legal opinion on share legality attached as Exhibit 5.1
Vertex Pharmaceuticals appointed Jonathan Poole as Executive Vice President and Chief Financial Officer on August 27, 2026, effective January 1, 2027. Charles F. Wagner, Jr. will stop serving as CFO on that date but will remain Executive Vice President and Chief Operating Officer. The filing discloses Mr. Poole's salary, bonus target and severance terms, which shareholders may review in the 10-Q exhibits later.
Jonathan Poole, 51, becomes EVP and CFO effective January 1, 2027, having been Senior Vice President, Finance at Vertex since March 2020
Charles F. Wagner, Jr. ceases to be CFO on the effective date and remains EVP and Chief Operating Officer
Poole's base salary is $750,000, with a target annual bonus of 90% of base salary
Severance on termination without cause or for good reason is 100% of base salary and target bonus; the change of control agreement covers the period from 90 days before to 12 months after a change of control
Raymond James Financial appointed William Weatherford, managing partner of Weatherford Capital, as a director, effective December 15, 2026, and increased the board from 12 to 13 seats. The company also declared a $0.54 per share quarterly dividend, payable October 15, 2026, and the filing reports no change to financial results or guidance.
Weatherford joins the Audit Committee and Risk Committee and is determined by the board to be independent; his appointment takes effect December 15, 2026.
The board size increased from twelve to thirteen directors.
Quarterly dividend of $0.54 per share, payable October 15, 2026 to shareholders of record on October 1, 2026.
Millrose Properties disclosed that on August 27, 2026 it amended its Founder's Rights Agreement with Lennar entities, changing the Priority Amount used for the Capital Priority Right and Lennar's secured financing collateral consent right. It also amended its Management Agreement with manager Kennedy Lewis Land and Residential Advisors, changing investment guidelines and the definition of Reimbursable Expenses. The filing does not give dollar amounts for either change, so the financial effect on shareholders cannot be measured from this document.
FRA Amendment dated August 27, 2026 adjusts the Priority Amount for the Capital Priority Right and Lennar's secured financing collateral consent right.
MA Amendment dated August 27, 2026 changes the scope of investment guidelines and the definition of Reimbursable Expenses.
The original Founder's Rights Agreement and Management Agreement were both entered into on February 7, 2025.
Chegg repaid the remaining $33.9 million of its 0% convertible senior notes due September 1, 2026, at maturity, leaving it with no outstanding debt. Pro forma for the repayment, the company would have had about $38 million in cash, cash equivalents, and investments, compared with $72 million reported as of June 30, 2026.
Repaid $33.9 million principal of 0% convertible senior notes due September 1, 2026, at maturity
Company states it now has no outstanding debt
Cash, cash equivalents, and investments of $72 million as of June 30, 2026; about $38 million pro forma for the repayment
Jones Ventures INTL Acquisition1 Corp, a blank check company, said holders of its units may separately trade Class A ordinary shares and rights starting September 3, 2026. Units not separated will continue to trade as JONEU, and the separated shares and rights will trade as JONE and JONER on Nasdaq. This is an administrative change that does not alter the company's financial position in the filing.
Separate trading begins September 3, 2026 for holders of units
Each unit consists of one Class A ordinary share and one right to receive one-eighth of a Class A ordinary share
No fractional rights will be issued; only whole rights will trade
Holders must have brokers contact VStock Transfer, LLC, the transfer agent, to separate units
FranklinCovey announced several executive leadership changes effective September 1, 2026, including M. Sean Covey moving from President, Education Division to Chief Product Officer and John Buchanan joining as Executive Vice President, Education. Operations chief Colleen Dom will retire effective June 1, 2027, with Adam Sherman set to succeed her. The changes concern senior management roles and do not include any reported financial results.
M. Sean Covey becomes Chief Product Officer effective September 1, 2026; his compensation will not change
John Buchanan joins as Executive Vice President, Education effective September 1, 2026, most recently Chief Growth Officer at GoGuardian
Colleen Dom retires as Executive Vice President, Operations effective June 1, 2027, with transition compensation totaling $98,000 plus an incremental short-term incentive award
Adam Sherman, Senior Vice President, Revenue and Customer Operations, will succeed Dom effective June 1, 2027
Avis Budget Group announced that Ravi Simhambhatla, Executive Vice President and Chief Digital & Innovation Officer, will leave the company. He will stay in his current role until September 30, 2026 to ensure a smooth transition. The filing contains no financial results or replacement details.
Ravi Simhambhatla, Executive Vice President and Chief Digital & Innovation Officer, is leaving the company
He remains in his current position until September 30, 2026
Callan JMB director Mark Meller resigned effective immediately on August 26, 2026, from the board and his roles as audit committee chair and governance and compensation committee member. The filing says the resignation was not due to any disagreement with the company on operations, policies or practices, and it ties the board change to an August 19, 2026 asset purchase agreement with Reger Oil, Inc. for oil and gas assets.
Mark Meller resigned from the board and as audit committee chair effective immediately on August 26, 2026.
If the Reger Oil asset purchase closes, holders of a majority of the stated value of Series A perpetual convertible preferred stock issued to the seller will nominate and elect a replacement director.
If the transaction does not close, remaining directors will fill the vacancy under the company's bylaws.
The filing states the resignation was not the result of any disagreement with the company.
Exodus Movement, Inc. disclosed that two of its officers, Jon Paul Richardson and Daniel Castagnoli, voluntarily cancelled all of their outstanding restricted stock units on August 31, 2026. The company says the cancellation adds share capacity under its 2026 Stock Incentive Plan to compensate employees and service providers tied to its long-term strategy and the integration of Monavate and Baanx.
Richardson cancelled 273,278 restricted stock units and Castagnoli cancelled 233,218 on August 31, 2026.
The cancelled units represented all of each officer's outstanding restricted stock units.
The freed share capacity is available under the 2026 Stock Incentive Plan for employee and service provider compensation.
The filing was signed September 1, 2026 by CFO James Gernetzke.
Greenlight Capital Re appointed John Welch as an independent director of the company and of Greenlight Reinsurance, effective September 1, 2026, and added him to the Audit, Compensation and Underwriting committees. The company also announced that Ariel Warszawski, elected by shareholders at its July 28, 2026 annual meeting, has joined the board. The filing describes board additions but gives no financial results, and the Greenlight Re appointment is subject to Cayman Islands Monetary Authority approval.
John Welch, age 61, appointed independent director effective September 1, 2026, and named to the Audit, Compensation and Underwriting committees
Welch's appointment to Greenlight Reinsurance, Ltd. board requires approval from the Cayman Islands Monetary Authority
Welch was Group Chief Underwriting Officer of Aspen Insurance Holdings from July 2025 to February 2026
Ariel Warszawski was elected to the board by shareholders at the July 28, 2026 Annual General Meeting
Mohawk Industries said on September 1, 2026 that An Nuyttens, a former Solvay executive, will become president of its Flooring Rest of the World segment effective mid-October, succeeding Paul De Cock, who has led the segment on an interim basis. The filing also says De Cock becomes chief executive officer effective September 30, 2026. The filing contains no financial results or guidance.
Nuyttens has more than 30 years of international leadership experience at Solvay, including senior executive roles in Europe and the United States.
Nuyttens takes over the segment effective mid-October 2026, replacing De Cock as interim leader.
Paul De Cock, Chief Operating Officer, becomes Chief Executive Officer effective September 30, 2026.
The segment serves customers in Europe, Asia-Pacific, Latin America and other international markets, including the Unilin business.
On August 28, 2026, Peoples Financial Services Corp. and its bank subsidiary amended the Supplemental Executive Retirement Plan agreement with former President Thomas P. Tulaney. The change adds a lifetime monthly payment after a twenty-year normal retirement benefit period, funded by an annuity contract the bank purchased.
Amendment approved August 28, 2026, with former President Thomas P. Tulaney
Bank bought an annuity contract to fund his normal retirement benefit under the SERP
If he survives the twenty-year benefit period, monthly payments continue for the rest of his life
Root, Inc. entered into agreements with Carvana on August 31, 2026, cancelling Carvana's long-term warrants issued October 1, 2021, and issuing a new warrant for up to 1,525,560 Class A shares, exercisable only if conditions tied to insurance sales through the Integrated Platform are met. The filing also amends the commercial agreement, investment agreement and registration rights agreement between the companies, including changes to term, non-renewal notice and exclusivity.
Carvana surrendered and Root cancelled all outstanding long-term warrants issued October 1, 2021
New warrant covers up to 1,525,560 Class A common shares, split into five tranches of 305,112 shares each
Each tranche is subject to conditions, including milestones tied to insurance sales through the Integrated Platform
Second Amendment to the Commercial Agreement changes term, non-renewal notice and exclusivity terms
Shuttle Pharmaceuticals Holdings signed a First Amendment to its April 30, 2026 Merger Agreement with its subsidiary United Dogecoin, lowering the Mining Rigs number in the Milestone Event from 2,000 to 500. The company says the cap on pre-funded warrants and shares issuable does not change, and it is seeking similar amendments to its PIPE Financing and Second Amendment to the Asset Purchase Agreement, which requires approval from investors and other parties.
Amendment dated August 31, 2026 reduces the Mining Rigs threshold in the Milestone Event from 2,000 to 500.
No other Merger Agreement terms were changed; the maximum number of pre-funded warrants issuable is unchanged.
The company is seeking parallel amendments to the Securities Purchase Agreement (1,910 shares of Series B-2 preferred stock, PIPE Financing closed May 6, 2026) and the Second Amendment to the Asset Purchase Agreement, which requires approva
Park Dental Partners said it identified unauthorized access to its computer network on August 28, 2026, and is investigating whether personal or protected health information was compromised. The company says the incident has not materially disrupted operations and has not identified any material impact on its financial condition, but it cannot yet estimate the financial, legal, operational or reputational impact.
Unauthorized network access identified on August 28, 2026; external cybersecurity and forensic specialists engaged
Company is treating the incident as a reportable event due to possible access to patient data
No material impact identified on financial condition, results of operations or business operations; an impact estimate is not yet reasonably possible
Investigation is ongoing and the assessment could change as more information becomes available
Mannatech said J. Stanley Fredrick will retire from its Board and as Chairman effective September 1, 2026, citing personal reasons and no disagreement with the company. Robert Toth, the Board's Vice Chairman and a Class III director, was appointed Chairman effective the same date. The filing also sets out Toth's chairman pay and continues Fredrick's director retainer through December 31, 2026 to support the transition.
Fredrick notified the Board on August 26, 2026; his retirement takes effect September 1, 2026.
Toth joined the Board as Vice Chairman on December 1, 2024, and previously served on the Board from March 2008 through May 31, 2023.
Toth's first-year chairman pay includes $50,000 in additional annual compensation and an equity award valued at $50,000, with the grant deferred until shareholder approval allows enough shares.
From his second year, Toth receives an additional $100,000 chairman fee on top of standard director compensation.
Sprouts Farmers Market said its board appointed President and Chief Operating Officer Nick Konat as chief executive and a director, effective January 4, 2027, the first day of its 2027 fiscal year. Jack Sinclair, CEO since June 2019, will become executive chairman at that time. The filing does not include financial results or guidance tied to the change.
Nick Konat, age 49, has been president and chief operating officer since March 2022 and previously held roles at Petco and Target.
Konat's annual base salary will rise to $1,000,000 on January 4, 2027, with a target bonus of 125% of salary and long-term equity incentive opportunity of 600% of salary.
Jack Sinclair becomes executive chairman with a $900,000 base salary, a 100% target bonus and a 333% long-term equity incentive opportunity.
The board will expand to nine members, and Chairman Joseph Fortunato will serve as lead independent director from the same date.
Alamar Biosciences appointed Robert Ragusa to its board of directors, effective September 1, 2026, as a Class I director with a term expiring at the 2027 annual meeting. He also joined the audit, compensation, and nominating and corporate governance committees. The filing describes this as a routine board addition with no related person transactions disclosed.
Robert Ragusa appointed to the Board by action on August 28, 2026, effective September 1, 2026
Class I director; initial term expires at the 2027 Annual Meeting of Stockholders
Also named to Audit, Compensation, and Nominating and Corporate Governance Committees
Compensated under the Non-Employee Director Compensation Policy described in the April 17, 2026 final prospectus
On August 31, 2026, Flexible Solutions International announced that director and audit committee chair John Bientjes resigned, with the company saying the resignation was not due to any disagreement on operations, policies, or practices. Dr. Kim Reid was appointed as a director and audit committee member, and David Fynn was named audit committee chair. The changes are board and committee personnel moves, and the filing reports no financial figures.
John Bientjes resigned as a director and as audit committee chairman, after nearly thirty years of service, per the August 31, 2026 press release.
Dr. Kim Reid was appointed a director and audit committee member, to serve until the next Annual Meeting.
David Fynn was appointed audit committee chairman.
Caterpillar and its finance arms signed a new $3.5 billion 364-day revolving credit facility and amended and extended two existing multi-year facilities, worth $3.0 billion and $5.0 billion. The facilities are available for general corporate purposes, and the borrowers had not drawn on them as of the filing date. The filing describes these as replacements and extensions of 2025 agreements, with covenants that include a minimum Caterpillar consolidated net worth of $9 billion.
364-day unsecured facility of $3.5 billion, expiring August 26, 2027, replaces the 2025 version
Three-year facility of $3.0 billion extended to August 27, 2029
Five-year facility of $5.0 billion extended to August 27, 2031
No borrowings under the facilities as of the filing date; Caterpillar must keep consolidated net worth of at least $9 billion
Otter Tail Corporation disclosed that directors Thomas J. Webb and Dr. Kathryn O. Johnson will retire from its Board of Directors when their current terms end at the 2027 Annual Meeting of Shareholders. Both moves follow the company's director retirement policy, and the company said neither reflects a disagreement with its operations, policies or procedures. The filing does not name replacements or address board size, so shareholders should watch for future board nominations.
Thomas J. Webb notified the company on August 28, 2026 that he will retire from the board at the end of his current term.
Kathryn O. Johnson notified the company on August 31, 2026 that she will retire, citing retirement age under the director retirement policy.
Both directors' terms expire at the 2027 Annual Meeting of Shareholders.
The company said neither departure results from a disagreement with its operations, policies or procedures.
Kustom Entertainment signed a Unit Purchase Agreement on August 31, 2026, to acquire all equity interests of TFL, LLC for $89.6 million in cash and $22.4 million in restricted common stock, with an additional $11.2 million in stock held back and tied to TFL's Target EBITDA through 2027. Closing requires conditions including third-party consents, stockholder approvals and sufficient funds, and either party may terminate if the deal is not completed by October 15, 2026. Shareholders would see new restricted shares issued and a seller-designated director join the board at closing.
Cash consideration of $89.6 million, subject to adjustments based mainly on TFL's closing net debt and transaction expenses
Stock consideration of $22.4 million in restricted common stock, priced on the 10-day volume weighted average trading price before closing
$11.2 million holdback in restricted shares, issued only if a specified Target EBITDA is achieved from closing through calendar year 2027
Company will repay $35.0 million of TFL indebtedness at closing; the agreement's outside date is October 15, 2026
Limbach Holdings announced on September 1, 2026 that it closed its acquisition of 1901 Inc., a Madison, Wisconsin mechanical contractor, for an initial price of $63 million, funded from cash and its expanded revolving credit facility. The company expects 1901 to contribute about $140 million in revenue and $11 million in adjusted EBITDA for 2027, and it will provide more detail on 1901's financial contribution with its third-quarter 2026 results in November.
Initial purchase price at closing of $63 million, subject to customary post-closing adjustments, funded by cash and revolver borrowings
Performance-based earnouts of up to $6 million, payable over the next two years if targets are met
1901 has about 450 employees, including more than 350 field professionals
For 2027, Limbach expects 1901 to contribute about $140 million in revenue and $11 million in adjusted EBITDA
Gyre Therapeutics made an updated corporate presentation available on its website on September 1, 2026, and furnished it as Exhibit 99.1 to a Form 8-K under Item 7.01 (Regulation FD Disclosure). The deck restates the company's FY26 total revenue guidance for ETUARY of $100.5M-$111M and a potential F351 launch in early 2027, and the filing itself reports no new financial results.
Presentation made available on the company's website on September 1, 2026; dated September 2026 and furnished as Exhibit 99.1.
ETUARY FY26 total revenue guidance shown as $100.5M-$111M.
F351 (hydronidone) NDA accepted by China's NMPA in May 2026, with potential launch after the NMPA decision in early 2027.
Idaho Copper reported on its fiscal second quarter ended July 31, 2026, citing its July 2, 2026 move to the NYSE American and an underwritten offering with approximately $18.0 million in gross proceeds. The company said it had about $12.1 million of cash on hand and expects to release an updated Preliminary Economic Assessment for its CuMo project in the near term. The filing reports no revenue, profit, or guidance figures, so the financial effect on shareholders is not quantified.
Common stock and publicly traded warrants began trading on the NYSE American on July 2, 2026 under COPR and COPR WS
Underwritten public offering with aggregate gross proceeds of approximately $18.0 million
Approximately $12.1 million of cash on hand, per CEO Andrew Brodkey
Bruce Harmon appointed Chief Financial Officer; updated PEA expected in the near term and will supersede the 2020 PEA
Chesapeake Utilities' subsidiary Peninsula Pipeline Holdings sold a 49% interest in the Florida Energy Pathway project to a unit of NextEra Energy Resources, and Peninsula keeps the remaining 51%. The project is estimated at about $1.2 billion in total investment, so the partner will share construction and funding obligations, while Chesapeake's parent guaranty of about $109 million backs its share of capital contributions.
NextEra unit FEP Pipeline Holdings, LLC acquired a 49% membership interest; Peninsula retains 51%, under an LLC agreement dated August 28, 2026, effective September 1, 2026.
Total project investment is estimated at approximately $1.2 billion, pending finalization of design and development activities.
Chesapeake's guaranty for Peninsula's capital contribution obligations is initially approximately $109 million.
Construction is expected to begin in the first half of 2028, with the project anticipated to be in service in 2030.
Figure Technology Solutions completed its previously announced acquisition of Kiavi, Inc. on September 1, 2026, paying approximately $590 million in cash, net of cash acquired, for Kiavi's technology platform and DSCR loans. The company said it primarily funded the deal with net proceeds from $600 million of 8.500% Senior Notes due 2031, and it repaid Kiavi's credit facility and terminated a related repurchase agreement at closing.
Cash consideration of approximately $590 million, net of cash acquired, subject to customary adjustments
Primarily funded by $600 million of 8.500% Senior Notes due 2031, which closed July 14, 2026
Kiavi's credit agreement and Deutsche Bank master repurchase agreement repaid or terminated at closing
Merger agreement was dated June 10, 2026; integration and synergy realization are listed as risks
Yum China Holdings furnished an interim report for the six months ended June 30, 2026, filed to comply with Hong Kong Stock Exchange listing rules. The 8-K itself contains no financial figures; the report is accessible via a link to the Hong Kong exchange filing, so shareholders must review that document for results.
Interim report covers the six months ended June 30, 2026.
Filed September 1, 2026 to comply with Hong Kong Stock Exchange listing rules.
The 8-K gives no revenue, profit, or guidance figures; they are in the linked Hong Kong filing.
Invivyd, Inc. appointed Chairman Marc Elia as Chief Executive Officer effective August 30, 2026, taking over as principal executive officer from William Duke, Jr., who remains Chief Financial Officer. The company also added Ian Sheffield to its board and named Ajay Royan Lead Independent Director, and the company said VYD2311 top-line data is still expected around the end of Q3 2026.
Marc Elia, Chairman since July 2022, became CEO effective August 30, 2026, and will also remain Chairman.
Elia's employment agreement provides a $750,000 base salary, a 70% target bonus, a $500,000 sign-on bonus, and an option to buy 10,700,000 shares.
Ian Sheffield was appointed a director on August 30, 2026, and Ajay Royan was named Lead Independent Director.
Invivyd expects top-line data from the VYD2311 program around the end of Q3 2026.
Upstream Bio announced its pivotal Phase 3 development plans for verekitug, a drug candidate in severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). The company remains on track to start both trials in the first quarter of 2027 and says it could seek approval and launch as early as 2030 if results are supportive. The filing contains no financial results, so the update is a development milestone rather than a change in reported financial performance.
Phase 3 plan: one placebo-controlled study in each indication, about 1,500 patients total, testing 400mg every 12 weeks
Asthma primary endpoint: annualized asthma exacerbation rates over 48 weeks
CRSwNP co-primary endpoints: change from baseline in nasal polyp score and nasal congestion score at 48 weeks
Trials expected to start in Q1 2027; potential U.S. launch as early as 2030 if Phase 3 results are supportive
Target Hospitality Corp. said it posted an investor presentation to its website on September 1, 2026. The filing furnishes the presentation under Regulation FD and does not state any financial results, guidance or other figures.
Presentation posted to the company's investor relations website on September 1, 2026.
Slides include forward-looking statements subject to a cautionary statement within the presentation.
Information is furnished under Item 7.01 and is not deemed filed under Section 18 of the Exchange Act.
AptarGroup expanded its board from ten to eleven directors and appointed Gael Touya as a director effective September 1, 2026. Touya also became President and Chief Executive Officer that day, succeeding Stephan B. Tanda, who retired; the CEO change was previously disclosed in a March 17, 2026 filing. For shareholders, this filing confirms the leadership transition and board addition, with no financial results or guidance included.
Gael Touya appointed director effective September 1, 2026, with term expiring at the 2028 annual meeting.
Board size increased from ten to eleven directors on August 29, 2026.
Touya, formerly President of the Aptar Pharma segment, became CEO on September 1, 2026, succeeding Stephan B. Tanda.
Touya will not receive additional pay for board service; CEO compensation was disclosed in the March 17, 2026 8-K.
Revolution Medicines agreed on August 27, 2026 to lease four buildings totaling about 672,000 rentable square feet in Redwood City, California, for its new headquarters. The leases carry about $2.7 million in monthly base rent at full commencement, with about $115.9 million in landlord tenant improvement allowances, and are contingent on the landlords acquiring the properties.
Four leases cover about 672,000 rentable square feet at 1600, 1700, 1800 and 1900 Seaport Boulevard, with commencement dates from September 26, 2027 through September 1, 2028.
Initial lease terms end in September 2042, with three five-year extension options.
Aggregate base rent starts at about $2.7 million per month, rising about 3% annually, with about $23.1 million in base rent abatement through January 2030.
Leases are effective only if the landlords complete the Phase II Closing; they terminate automatically if it has not occurred by April 29, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.